MaxCyte, Inc. (MXCT) Social Stream
MAXCYTE INC (MXCT) Price Targets From Analysts
Use the tables below to see what analysts covering MAXCYTE INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $22 | $18 | $19.667 | $5.35 | 267.61% |
| 2022-03-22 | 5 | $22 | $18 | $19.666 | $5.35 | 267.59% |
| 2022-04-01 | 5 | $22 | $17 | $19 | $5.35 | 255.14% |
| 2022-05-09 | 5 | $22 | $16 | $18.333 | $5.35 | 242.67% |
| 2022-08-10 | 5 | $22 | $15 | $17.666 | $5.35 | 230.21% |
| 2022-08-15 | 5 | $16 | $11 | $14 | $5.35 | 161.68% |
| 2022-12-01 | 4 | $16 | $11 | $13.666 | $5.35 | 155.44% |
| 2023-03-15 | 5 | $14 | $11 | $12.333 | $5.35 | 130.52% |
| 2023-08-09 | 5 | $12 | $11 | $11.666 | $5.35 | 118.06% |
| 2023-09-01 | 4 | $12 | $12 | $12 | $5.35 | 124.3% |
| 2023-11-01 | 4 | $12 | $11 | $11.5 | $5.35 | 114.95% |
| 2023-11-09 | 4 | $11 | $11 | $11 | $5.35 | 105.61% |
| 2023-11-13 | 4 | $11 | $7 | $9.666 | $5.35 | 80.67% |
| 2023-11-29 | 5 | $11 | $7 | $9 | $5.35 | 68.22% |
| 2023-12-05 | 5 | $11 | $7 | $9.75 | $5.35 | 82.24% |
The Trend in the Analyst Price Target
Over the past 118 days, MXCT's average price target has gone down $1.92.
MXCT reports an average of 170.11% for its upside potential over the past 38 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-15 | 5 | 14 | 11 | 12.333 | 4.20 | 193.64% |
| 2023-03-28 | 5 | 12 | 11 | 11.666 | 4.08 | 185.93% |
| 2023-09-01 | 4 | 12 | 12 | 12.000 | 3.70 | 224.32% |
| 2023-11-01 | 4 | 12 | 11 | 11.500 | 3.28 | 250.61% |
| 2023-11-13 | 4 | 11 | 7 | 9.666 | 3.48 | 177.76% |
MXCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
MXCT's average broker recommendation rating improved by 0 over the prior 19 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, MAXCYTE INC's average analyst price target is higher than 327.84% of them.
- In the context of all US stocks, MAXCYTE INC's upside potential (average analyst target price relative to current price) is higher than 1738.21% of them.
- In terms of how MAXCYTE INC fares relative to Business Services stocks, note that its number of analysts covering the stock is higher than 243.92% of that group.
- MXCT has a lower variance in analysts' estimates than -316.42% of Business Services stocks.
In the Business Services industry, HEES, SY, and GRNQ are the three stocks most similar to MAXCYTE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is MXCT a Buy, Hold or Sell? See the POWR Ratings now!